Biochemical aspects of the phosphoinositide signalling system with special emphasis on the inositol cyclic phosphates and arachidonate
Hokin, L.E.; Dixon, J.F.; Reichman, M.; Sekar, M.C.
Progress in Clinical and Biological Research 249: 149-158
1987
ISSN/ISBN: 0361-7742 PMID: 2823290 Document Number: 296494
Document emailed within 1 workday
Related Documents
Kohn, E.C.; Sandeen, M.A.; Liotta, L.A. 1992: In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates Cancer Research 52(11): 3208-3212Khac, L.D.; Mokhtari, A.; Renner, M.; Harbon, S. 1992: Activation of beta-adrenergic receptors inhibits Ca2+ entry-mediated generation of inositol phosphates in the guinea pig myometrium, a cyclic AMP-independent event Molecular Pharmacology 41(3): 509-519
Strunecká, A.; Kmonícková, E.; Krpejsová, L.; el Desouki, N.I.; Hrusová, H.; Palecek, J. 1990: Phosphoinositide signalling system in human erythrocyte and its role in cell pathology Biomedica Biochimica Acta 49(2-3): S141-S146
Manzoli, L.; Billi, A.M.; Faenza, I.; Matteucci, A.; Martelli, A.M.; Peruzzi, D.; Falconi, M.; Rhee, S.G.; Gilmour, R.S.; Cocco, L. 1999: Nuclear phospholipase C: a novel aspect of phosphoinositide signalling Anticancer Research 19(5a): 3753-3756
Watanabe, Y. 1999: Synthesis of inositol phosphates and phospholipids Anticancer Research 19(5a): 3727-3732
Stepanov, A.E.; Shvets, V.I. 1996: Biologically active myo-inositol phosphates Bioorganicheskaia Khimiia 22(10-11): 737-744
Frandsen, E.; Geisler, A.; Madsen, S.N. 1975: Cyclic AMP. Biochemical and clinical aspects Ugeskrift for Laeger 137(22): 1193-1196
Amiot, F.; Leiber, D.; Marc, S.; Harbon, S. 1993: GRP-preferring bombesin receptors increase generation of inositol phosphates and tension in rat myometrium American Journal of Physiology 265(6 Pt 1): C1579-C1587
Marin, P.; Stella, N.; Cordier, J.; Glowinski, J.; Prémont, J. 1993: Role of arachidonic acid and glutamate in the formation of inositol phosphates induced by noradrenalin in striatal astrocytes Molecular Pharmacology 44(6): 1176-1184
Yang, G.Y.; Shamsuddin, A.M. 1995: IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates Anticancer Research 15(6b): 2479-2487
Rosenbergová, M.; Pristasová, S.; Prachar, J. 1981: Hydrolysis of ribonucleoside 2',3'-cyclic phosphates by influenza and Newcastle disease viruses Acta Virologica 25(2): 71-77
Gusovsky, F.; Yasumoto, T.; Daly, J.W. 1989: Calcium-dependent effects of maitotoxin on phosphoinositide breakdown and on cyclic AMP accumulation in PC12 and NCB-20 cells Molecular Pharmacology 36(1): 44-53
Winder, D.G.; Smith, T.; Conn, P.J. 1993: Pharmacological differentiation of metabotropic glutamate receptors coupled to potentiation of cyclic adenosine monophosphate responses and phosphoinositide hydrolysis Journal of Pharmacology and Experimental Therapeutics 266(2): 518-525
Kuska, J.; Germakowska-Kowalik, T.; Pluta, S. 1982: Renin-angiotensin system inhibitors - biochemical and clinical aspects Postepy Higieny i Medycyny Doswiadczalnej 35(4): 395-411
Kowal, P. 1992: Biochemical, rheological and clinical aspects of using the HELP system in the treatment of hypercholesterolemia and cerebrovascular disorders Neurologia i Neurochirurgia Polska 26(4): 538-544
Silver, P.J.; Lepore, R.E.; O'Connor, B.; Lemp, B.M.; Hamel, L.T.; Bentley, R.G.; Harris, A.L. 1988: Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone Journal of Pharmacology and Experimental Therapeutics 247(1): 34-42
Il'in, I.I.; Begam, R.; Mal'tsev, E.V.; Moiseev, I.N. 1986: Various neurochemical aspects of the action of the tetrapeptide tuftsin on limbic system structures (histochemical and biochemical study) Arkhiv Anatomii Gistologii i Embriologii 90(2): 53-57
DasGupta, K.; Weiler, M.H. 1992: Age-related differences in the phosphoinositide system in rat neostriatum Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 7(2): 163-165
Möller, H.; Wirbitzki, E. 1993: Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system Bollettino Chimico Farmaceutico 132(4): 105-115
Bass, E.M. 1975: The radiological diagnosis of hepatoma with special emphasis on angiography South African Medical Journal 49(18): 745-751